Article Versions Notes

Tuomainen K, Al-Samadi A, Potdar S, Turunen L, Turunen M, Karhemo P-R, Bergman P, Risteli M, Åström P, Tiikkaja R, et al. Human Tumor–Derived Matrix Improves the Predictability of Head and Neck Cancer Drug Testing. Cancers. 2020; 12(1):92. https://doi.org/10.3390/cancers12010092

Tuomainen, Katja, Ahmed Al-Samadi, Swapnil Potdar, Laura Turunen, Minna Turunen, Piia-Riitta Karhemo, Paula Bergman, Maija Risteli, Pirjo Åström, Riia Tiikkaja, and et al. 2020. "Human Tumor–Derived Matrix Improves the Predictability of Head and Neck Cancer Drug Testing" Cancers 12, no. 1: 92. https://doi.org/10.3390/cancers12010092

Tuomainen, K., Al-Samadi, A., Potdar, S., Turunen, L., Turunen, M., Karhemo, P.-R., Bergman, P., Risteli, M., Åström, P., Tiikkaja, R., Grenman, R., Wennerberg, K., Monni, O., & Salo, T. (2020). Human Tumor–Derived Matrix Improves the Predictability of Head and Neck Cancer Drug Testing. Cancers, 12(1), 92. https://doi.org/10.3390/cancers12010092